|
|
|
Insider
Information: |
Tang Kevin C |
Relationship: |
Director, 10% Owner |
City: |
Durham |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
1,283,539 |
|
Indirect Shares
|
16,080,253 |
|
|
Direct
Value |
$71,538,178 |
|
|
Indirect Value
|
$20,175,125 |
|
|
Total
Shares |
17,363,792 |
|
|
Total
Value |
$91,713,303 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
Director |
2008-12-15 |
6,300 |
2008-12-15 |
4,100 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2012-06-19 |
0 |
2012-06-19 |
0 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2006-10-23 |
25,000 |
2006-10-23 |
304,736 |
Premium* |
|
Questcor Pharmaceuticals Inc |
QCOR |
10% Owner |
|
0 |
2007-11-13 |
6,718,860 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-04-02 |
27,000 |
2008-04-02 |
3,238,400 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2013-07-12 |
1,218,298 |
|
0 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
Director |
2019-10-04 |
6,941 |
2019-10-04 |
5,814,157 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
Director, 10% Owner |
2022-08-22 |
0 |
2022-08-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
26 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
26 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|